MedPath

The effects of intranasal insulin on glucose metabolism in healthy me

Conditions
Diabetes
10018424
Registration Number
NL-OMON33430
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Healthy men, ages between 18 and 35 years, BMI between 20 and 25 kg/m2, with a normal oral glucose tolerance test.

Exclusion Criteria

* any medication or substance use
* diabetes mellitus II (DM II) in first degree family members
* smoking
* alcohol abuse ( >3/day)
* lipid disorders, renal insufficiency, elevated liver enzymes or TSH
* bleeding disorders
* prior surgery of the nose and/or septum
* allergic rhinitis
* known allergies to antibiotics, used as prophylaxis in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Endogenous glucose production.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Insulin concentration in de cerebrospinal fluid<br /><br>glucoregulatory hormones</p><br>
© Copyright 2025. All Rights Reserved by MedPath